We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

94 hedge funds and large institutions have $538M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

4% less capital invested

Capital invested by funds: $560M → $538M (-$21.7M)

5% less funds holding

Funds holding: 99 → 94 (-5)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
94
Holders Change
-5
Holders Change %
-5.05%
% of All Funds
2.71%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
38
Reduced
32
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$25.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$11.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.2M
4
State Street
State Street
Massachusetts
+$10.1M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$7.63M

Top Sellers

Rank Fund Capital Flow
1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$12.9M
2
CS
Credit Suisse
Switzerland
-$12.8M
3
Jennison Associates
Jennison Associates
New York
-$11M
4
BIM
Bogle Investment Management
Massachusetts
-$4.27M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$4.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Senzar Asset Management
New York
$3.16M +$2.96M +135,400 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.75M -$554K -25,324 -18%
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$1.82M +$432K +19,733 +34%
Canada Life
29
Canada Life
Manitoba, Canada
$1.79M – – –
TCIM
30
TIAA CREF Investment Management
New York
$1.78M -$35.2K -1,610 -2%
WMSA
31
Weiss Multi-Strategy Advisers
New York
$1.75M +$109K +5,000 +7%
PCP
32
Perimeter Capital Partners
Georgia
$1.71M -$847K -38,747 -35%
Ohio Public Employees Retirement System (OPERS)
33
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.58M -$187K -8,529 -11%
CCMH
34
Cornerstone Capital Management Holdings
New York
$1.54M -$838K -38,300 -37%
FLAM
35
First Light Asset Management
Minnesota
$1.52M +$202K +9,237 +17%
MAA
36
Managed Account Advisors
New Jersey
$1.29M +$156K +7,116 +15%
RFC
37
Russell Frank Company
Washington
$1.28M +$114K +5,195 +9%
QBFM
38
QS Batterymarch Financial Management
New York
$1.24M – – –
BIM
39
BlackRock Investment Management
Delaware
$1.22M +$18.1K +828 +2%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$1.18M -$970K -44,371 -47%
ProShare Advisors
41
ProShare Advisors
Maryland
$1.01M +$613K +28,042 +183%
DCM
42
Dupont Capital Management
Delaware
$902K -$858K -39,217 -50%
AI
43
Analytic Investors
California
$838K +$462K +21,134 +144%
GT
44
Glenmede Trust
Pennsylvania
$833K – – –
ARTA
45
A.R.T. Advisors
New York
$811K +$203K +9,297 +37%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$800K +$4.37K +200 +0.6%
BRWA
47
B. Riley Wealth Advisors
Florida
$659K -$2.46M -112,674 -80%
TA
48
Teachers Advisors
New York
$644K +$49K +2,240 +9%
AllianceBernstein
49
AllianceBernstein
Tennessee
$605K -$54.7K -2,500 -9%
PAMU
50
Pictet Asset Management (UK)
United Kingdom
$598K +$59K +2,700 +12%
1
2
3 4 5

SGNT Hedge Fund Activity: Q1 2014 in Review

94 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2014, worth a combined $538M — down 3.9% from $560M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of SGNT and 14 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 38 added.

The largest buyer was Franklin Resources, adding an estimated $25.8M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $12.9M sold.

  • 94 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2014, down from 99 in Q4 2013.
  • Funds reported $538M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014, down 3.9% quarter-over-quarter.
  • 14 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 19 closed out, a net change of -5 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Franklin Resources, an estimated $25.8M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2014 was Loomis, Sayles & Company, an estimated $12.9M sold.

Based on aggregated 13F filings for Q1 2014.